Imaging veteran Mason joins eMed as CEO

Article

Imaging veteran Mason joins eMed as CEOPACS and imaging veteran Caren Mason has joined eMed Technologies as CEO in a move intended to strengthen the company’s resources as it broadens into Web-based image workflow products and services.

Imaging veteran Mason joins eMed as CEO

PACS and imaging veteran Caren Mason has joined eMed Technologies as CEO in a move intended to strengthen the company’s resources as it broadens into Web-based image workflow products and services. Former CEO and president Scott Sheldon continues as president of the Lexington, MA-based firm and will work closely with Mason to further eMed’s growth and expansion.

Mason brings to eMed more than 20 years’ experience in healthcare imaging and information businesses, most recently as general manager of the Women’s Healthcare business for General Electric. Prior to GE she was senior vice president of the technical imaging business group for Agfa, where she headed up the Agfa Medical, Motion Picture, Nondestructive Testing, and Micrographics businesses. She has also held management positions at Baxter Healthcare.

© 2000 Miller Freeman, Inc., a United News & Media company

Recent Videos
Improving Access to Nuclear Imaging: An Interview with SNMMI President Jean-Luc C. Urbain, MD, PhD
SNMMI: 18F-Piflufolastat PSMA PET/CT Offers High PPV for Local PCa Recurrence Regardless of PSA Level
SNMMI: NIH Researcher Discusses Potential of 18F-Fluciclovine for Multiple Myeloma Detection
SNMMI: What Tau PET Findings May Reveal About Modifiable Factors for Alzheimer’s Disease
Emerging Insights on the Use of FES PET for Women with Lobular Breast Cancer
Can Generative AI Reinvent Radiology Reporting?: An Interview with Samir Abboud, MD
Mammography Study Reveals Over Sixfold Higher Risk of Advanced Cancer Presentation with Symptom-Detected Cancers
Combining Advances in Computed Tomography Angiography with AI to Enhance Preventive Care
Study: MRI-Based AI Enhances Detection of Seminal Vesicle Invasion in Prostate Cancer
What New Research Reveals About the Impact of AI and DBT Screening: An Interview with Manisha Bahl, MD
Related Content
© 2025 MJH Life Sciences

All rights reserved.